Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JAN.........................................https://stockcharts.com/h-sc/ui?s=JAN&p=W&b=5&g=0&id=p86431144783
Definitely getting found now,when they turn JAN loose ohhh boy can she run,very predictable charting.love it!!
Rose above $2 which is enough to qualify for the Barchart 100
Be u ti full
JAN.......................................https://stockcharts.com/h-sc/ui?s=JAN&p=W&b=5&g=0&id=p86431144783
JAN......................................https://stockcharts.com/h-sc/ui?s=JAN&p=W&b=5&g=0&id=p86431144783
out with 125% win,momo fading,getting risky,next
ANY NEWS ????????
shares ava. dropped from 300k to 200k,on way to ZERO BORROW,back in .80
JAN: And THANKS again, Dude!! (& we both DID have fun on that Puppy!!!)
you and i slayed the hell out of last time,figured you might want to know
JAN: Heck, Bro, I didn't expect a reply to one of my Pre-Columbian iHub posts!!! (But heck, THANKS for the heads-up, Homeboy!!)
its moving again,not zero borrow(or reducing yet,watching close for it)
JAN..................................https://stockcharts.com/h-sc/ui?s=JAN&p=W&b=5&g=0&id=p86431144783
Rather belatedly, but THANKS Commander Infiniti!!!
Sorry to hear that gl next time lol
Yea so good chased .7 now bag lol
Dr. Soin's appearance extends JanOne's busy period of recent announcements. On August 29, the company revealed it had received a US Patent for use of its novel formulation of low-dose naltrexone (Jan123) to treat chronic pain. Tony Isaac, JanOne's CEO, said that the new patent's broad language—covering methods of using JanOne's formulation of low-dose naltrexone to treat chronic pain—"provides robust and broad coverage and protection, and lengthens the timeline for sales significantly."
Also in August, Dr. Soin's team won a prestigious "Best Abstract" award for reporting that JanOne's treatment for diabetic neuropathy showed both effectiveness against pain and potential to improve nerve function. The abstract, which was presented to the influential Ohio Society of Interventional Pain Physicians (OHSIPP), analyzed prior data on Jan101's randomized double blind placebo-controlled trial in diabetic neuropathy patients.
More recently–in early September—Dr. Soin had another opportunity to engage investors focused on innovative growth companies. He presented to H.C. Wainwright's 25th Annual Global Investment Conference.
CEO Isaac commented on the company's recent visibility: "We're being invited to tell our story about new approaches to treating pain and underlying causes of pain," he said. "Thousands continue to suffer from opioid-related addiction and deaths. Our mission—to find non-addictive alternatives—has never been more relevant or more urgent."
JAN .54's dip, see if .50 HOLDS for after hours push back to .70?
JAN: Good supplemental points there, 81-V; especially in light of the EXPANSIVE burden the Addiction-Pain-Opioids problem places upon the World at large. (And perhaps looming news behind JAN's US & Canadian 'APPLIANCE RECYCLING' divisions??)
so you figure this is far from done?
News overdue>worldwide patent,fda trial
JAN: I'll bet that you're a CARDIOLOGIST, when not playin' the stocks. (Hey, all jokin' aside, the crazy up-&-down monster 'heartbeat' on this one may go on right through the POST-MARKET, to boot.)
I woke up at 3am saw this one had no news but was up a little in premarket had a slow heart beat but someone pulled out the defibrillator and woke it up
JAN: We will ALL remember THIS one, Bro!!! WOW!! What a spectacle!!!
Nice find today bro,thanks to you also!!,Thru .75 could blow to .95(sma200 daily) we slayed em today for sure !!!
JAN: Hey, King Infiniti --- oh, by-the-way, THANKS for your many, many ALERTS here --- just maybe there IS a God!!! (Amén, again!)
JAN: I've seen them all, Admiral K., but NEVER one quite like this!! And in just ONE frickin' day.
Huge buys, has to be institutional loading for what is coming Mon. Weeee and hawww bro!!
Followers
|
19
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1487
|
Created
|
08/24/09
|
Type
|
Free
|
Moderators |
Volume: | - |
Day Range: | |
Last Trade Time: |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |